Bartoszyk GD - Search Results

1

Electrophysiological evidence for rapid 5-HT₁A autoreceptor inhibition by vilazodone, a 5-HT₁A receptor partial agonist and 5-HT reuptake inhibitor.

Ashby CR Jr, Kehne JH, Bartoszyk GD, Renda MJ, Athanasiou M, Pierz KA, Seyfried CA. Ashby CR Jr, et al. Among authors: bartoszyk gd. Eur J Pharmacol. 2013 Aug 15;714(1-3):359-65. doi: 10.1016/j.ejphar.2013.07.014. Epub 2013 Jul 16. Eur J Pharmacol. 2013. PMID: 23872377 Free article.

2

EMD 281014, a new selective serotonin 5-HT2A receptor antagonist.

Bartoszyk GD, van Amsterdam C, Böttcher H, Seyfried CA. Bartoszyk GD, et al. Eur J Pharmacol. 2003 Jul 25;473(2-3):229-30. doi: 10.1016/s0014-2999(03)01992-7. Eur J Pharmacol. 2003. PMID: 12892843

3

The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test.

Patel JG, Bartoszyk GD, Edwards E, Ashby CR Jr. Patel JG, et al. Among authors: bartoszyk gd. Synapse. 2004 Apr;52(1):73-5. doi: 10.1002/syn.10308. Synapse. 2004. PMID: 14755634

4

Sensitivity of dopamine D2 receptors following long-term treatment with roxindole.

Seyfried CA, Bartoszyk GD. Seyfried CA, et al. Among authors: bartoszyk gd. Eur J Pharmacol. 1994 May 12;257(1-2):67-72. doi: 10.1016/0014-2999(94)90695-5. Eur J Pharmacol. 1994. PMID: 7915991

5

Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.

Heinrich T, Böttcher H, Gericke R, Bartoszyk GD, Anzali S, Seyfried CA, Greiner HE, Van Amsterdam C. Heinrich T, et al. Among authors: bartoszyk gd. J Med Chem. 2004 Sep 9;47(19):4684-92. doi: 10.1021/jm040793q. J Med Chem. 2004. PMID: 15341484

6

Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.

Heinrich T, Böttcher H, Schiemann K, Hölzemann G, Schwarz M, Bartoszyk GD, van Amsterdam C, Greiner HE, Seyfried CA. Heinrich T, et al. Among authors: bartoszyk gd. Bioorg Med Chem. 2004 Sep 15;12(18):4843-52. doi: 10.1016/j.bmc.2004.07.014. Bioorg Med Chem. 2004. PMID: 15336263

7

Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats.

Adamec R, Bartoszyk GD, Burton P. Adamec R, et al. Among authors: bartoszyk gd. Eur J Pharmacol. 2004 Nov 3;504(1-2):65-77. doi: 10.1016/j.ejphar.2004.09.009. Eur J Pharmacol. 2004. PMID: 15507223

8

Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.

Barber A, Bartoszyk GD, Greiner HE, Mauler F, Murray RD, Seyfried CA, Simon M, Gottschlich R, Harting J, Lues I. Barber A, et al. Among authors: bartoszyk gd. Br J Pharmacol. 1994 Mar;111(3):843-51. doi: 10.1111/j.1476-5381.1994.tb14815.x. Br J Pharmacol. 1994. PMID: 8019761 Free PMC article.

9

Indolebutylamines as selective 5-HT(1A) agonists.

Heinrich T, Böttcher H, Bartoszyk GD, Greiner HE, Seyfried CA, Van Amsterdam C. Heinrich T, et al. Among authors: bartoszyk gd. J Med Chem. 2004 Sep 9;47(19):4677-83. doi: 10.1021/jm040792y. J Med Chem. 2004. PMID: 15341483

10

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA. Hughes ZA, et al. Among authors: bartoszyk gd. Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57. doi: 10.1016/j.ejphar.2005.01.018. Eur J Pharmacol. 2005. PMID: 15740724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters